Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

European Respiratory Society guideline on various aspects of quality in lung cancer care.

The European respiratory journal·2022
Same author

Critically ill cancer patient's resuscitation: a Belgian/French societies' consensus conference.

Intensive care medicine·2021
Same author

Initiation of a new anti-cancer medical treatment in ICU: a retrospective study.

Acta clinica Belgica·2021
Same author

Sepsis and Septic Shock Definitions in Patients With Cancer Admitted in ICU.

Journal of intensive care medicine·2019
Same author

Immune evasion before tumour invasion in early lung squamous carcinogenesis.

Nature·2019
Same author

Bullous Lupus Under Nivolumab Treatment for Lung Cancer: A Case Report With Systematic Literature Review.

Anticancer research·2019

Related Experiment Video

Updated: May 13, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

Nonsmall cell lung cancer.

Jean-Paul Sculier1

  • 1Université Libre de Bruxelles (ULB), Institut Jules Bordet, Service des Soins Intensifs et Urgences Oncologiques, Brussels, Belgium. sculier@bordet.be

European Respiratory Review : an Official Journal of the European Respiratory Society
|March 5, 2013
PubMed
Summary

This review summarizes the 2012 European Respiratory Society Congress proceedings on nonsmall cell lung cancer (NSCLC). It covers key advancements in NSCLC epidemiology, diagnosis, treatment, and palliative care.

Area of Science:

  • Pulmonology
  • Oncology

Background:

  • Nonsmall cell lung cancer (NSCLC) remains a significant global health challenge.
  • Regular updates on NSCLC research are crucial for clinical practice.

Purpose of the Study:

  • To summarize key findings presented at the 2012 European Respiratory Society Congress.
  • To provide an overview of the latest developments in NSCLC management.

Main Methods:

  • Review of presentations from the 2012 European Respiratory Society Congress.
  • Synthesis of information on epidemiology, screening, diagnosis, treatment, prognosis, and palliative care for NSCLC.

Main Results:

  • The congress covered diverse aspects of NSCLC, highlighting recent research and clinical insights.

More Related Videos

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Related Experiment Videos

Last Updated: May 13, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

  • Key topics included updates on early detection, novel therapeutic strategies, and end-of-life care.

    • Conclusions:

    • The 2012 European Respiratory Society Congress provided valuable insights into the evolving landscape of NSCLC.
    • Continuous review of such proceedings is essential for advancing patient care in NSCLC.